Clinical Trial: Midostaurin in Indolent Systemic Mastocytosis

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Phase II Single Arm Open Pilot Study to Demonstrate the Efficacy of Midostaurin in Symptom Improvement and Decrease of Mast Cell Burden in Patients With Indolent or Smoldering Systemic